The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
$UBX insiders have traded $UBX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales. Here’s a ...
The latest price target for Unity Biotechnology (NASDAQ:UBX) was reported by HC Wainwright & Co. on May 27, 2025. The analyst firm set a price target for $2.00 expecting UBX to rise to within 12 ...
Investors might want to bet on UNITY Biotechnology, Inc. (UBX), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful ...
Unity Biotechnology (NASDAQ:UBX) just reported results for the first quarter of 2024. Unity Biotechnology reported earnings per share of -34 cents. This was above the analyst estimate for EPS of -48 ...
We at Insider Monkey have gone over 866 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the funds’ and investors’ portfolio positions as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results